BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Diagnosis
128 results:

  • 1. LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.
    Huang R; Kong Y; Luo Z; Li Q
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674418
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
    Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
    Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
    [No Abstract]    [Full Text] [Related]  

  • 4. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors.
    Zhang Y; Zhong C; Ke X; Liu J; Ye Z; Lu L; Deng K; Zhu H; Yao Y
    Acta Neuropathol Commun; 2023 Nov; 11(1):188. PubMed ID: 38012690
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Protein Disulfide Isomerase A2 Is Correlated with Immune Infiltrates and Is a Novel Prognostic Biomarker in Glioma Patients.
    Ma ZG; Liu YX; Zou N; Huang Z; Wang M; Li T; Zhou J; Chen LG
    Curr Med Sci; 2023 Dec; 43(6):1107-1115. PubMed ID: 37978154
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A scoping review of interpretability and explainability concerning artificial intelligence methods in medical imaging.
    Champendal M; Müller H; Prior JO; Dos Reis CS
    Eur J Radiol; 2023 Dec; 169():111159. PubMed ID: 37976760
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Glioblastoma CircularRNAome.
    Tirpe A; Streianu C; Tirpe SM; Kocijancic A; Pirlog R; Pirlog B; Busuioc C; Pop OL; Berindan-Neagoe I
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833993
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Early death after a diagnosis of metastatic solid cancer-raising awareness and identifying risk factors from the SEER database.
    Globus O; Sagie S; Lavine N; Barchana DI; Urban D
    PLoS One; 2023; 18(9):e0281561. PubMed ID: 37751439
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Classification and Molecular diagnosis of Benign brain Tumors].
    Yoshimoto K
    No Shinkei Geka; 2023 Sep; 51(5):771-777. PubMed ID: 37743328
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.
    Chen M; Duan L; Sun W; Guo Z; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
    Neuroendocrinology; 2023; 113(9):971-986. PubMed ID: 37253344
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pituitary Tumorigenesis-Implications for Management.
    Vamvoukaki R; Chrysoulaki M; Betsi G; Xekouki P
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109772
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients.
    Han W; Chen L
    Mol Carcinog; 2023 Jul; 62(7):975-990. PubMed ID: 37036189
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Approach to the Patient With Prolactinoma.
    Auriemma RS; Pirchio R; Pivonello C; Garifalos F; Colao A; Pivonello R
    J Clin Endocrinol Metab; 2023 Aug; 108(9):2400-2423. PubMed ID: 36974474
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. brain metastases of papillary thyroid carcinoma origin are derived from aggressive histologic variants and demonstrate similar adverse morphology in the metastatic lesion.
    Gubbiotti MA; Livolsi V
    Clin Neurol Neurosurg; 2023 Apr; 227():107639. PubMed ID: 36889238
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Outcome and prognostic factors for pituitary carcinomas: lessons from a systematic review.
    Raymond P; Raverot G; Ilie MD
    Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36852675
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Thyroid carcinoma metastases to central nervous system and vertebrae.
    Kleinschmidt-DeMasters B; Marshall C
    Folia Neuropathol; 2022; 60(3):292-300. PubMed ID: 36382481
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Novel
    Deland L; Keane S; Bontell TO; Fagman H; Sjögren H; Lind AE; Carén H; Tisell M; Nilsson JA; Ejeskär K; Sabel M; Abel F
    Cancer Genomics Proteomics; 2022; 19(6):711-726. PubMed ID: 36316040
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Influence of COVID-19 pandemic on the decision making of patients in undergoing gamma knife radiosurgery.
    Shen CC; Jiang RS; Yang MY; You WC; Sun MH; Sheu ML; Pan LY; Sheehan J; Pan HC
    Eur J Med Res; 2022 Oct; 27(1):223. PubMed ID: 36309708
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. NOLC1 knockdown suppresses prostate cancer progressions by reducing akt phosphorylation and β-catenin accumulation.
    Kim W; Yeo DY; Choi SK; Kim HY; Lee SW; Ashim J; Han JE; Yu W; Jeong H; Park JK; Park S
    Biochem Biophys Res Commun; 2022 Dec; 635():99-107. PubMed ID: 36265288
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.